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Abstract
Objective: To measure surrogate markers of coagulation activation as well as of the systemic inflammatory response in patients undergoing
primary elective coronary artery bypass grafting (CABG) using either the so-called Smart suction device or a continuous autotransfusion system
(C.A.T.S.W).Methods: Fifty-eight patients being operated with a miniaturized circuit (minimal extracorporeal circuit, MECC) were prospectively
randomized to using a so-called Smart suction device or a routine continuous autotransfusion system (C.A.T.S.W) for collection ofmediastinal shed
blood. The coagulation response was measured by thrombin—antithrombin complex (TAT) and D-dimer. The inflammatory response was measured
by Interleukin 6 (IL-6) and complement factor 3a (C3a) at three different time points, before surgery, 2 h after surgery, as well as 18 h after
surgery. Results: No serious adverse cardiovascular event was observed. Serum levels of TATsignificantly differed between both groups 2 h after
surgery (Smart suction 16.12  13.51 mg l1 vs C.A.T.SW 9.83  7.81 mg l1, p = 0.040) and returned to baseline values after 18 h in both groups.
Serum levels of D-dimer showed a corresponding pattern with a peak 2 h after surgery (Smart suction 1115  1231 ng ml1 vs C.A.T.S.W
507  604 ng ml1, p = 0.025). IL-6 levels also significantly differed between both groups 2 h after surgery (Smart suction 186  306 pg ml1 vs
C.A.T.S.W 82  71 pg ml1, p = 0.072). No significant changes in serum levels of C3a over time could be observed. Conclusions: Despite no
differences in the clinical course of patients with either Smart suction or C.A.T.S.W being observed, surrogate markers of coagulation and
inflammation seem to be less pronounced in patients where cardiotomy blood is not being directly reinfused. As such, C.A.T.S.W should be
preferred in routine CABG, as long as no extensive volume substitution is anticipated.
# 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
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Cardiopulmonary bypass (CPB) is known to cause coagula-
tion activation as well as a systemic inflammatory response
[1—3]. To reduce the detrimental effects of inflammatory
mediators, elimination of shed blood from the wound was
regarded essential and autotransfusion systems have been
proven to dramatically reduce this [4,5]. Recent develop-
ments have successfully reduced the foreign surface and have
established the new concept of volume-controlled perfusion
[6,7]. This minimal extracorporeal circuit (MECC) has been
introduced into clinical routine recently. However, the same
question as in conventional CPB arose regarding coagulation
activation as well as systemic inflammatory response [8].* Corresponding author. Tel.: +41 31 632 2376; fax: +41 31 632 29 19.
E-mail address: mario.stalder@insel.ch (M. Stalder).
1010-7940/$ — see front matter # 2011 European Association for Cardio-Thoracic
doi:10.1016/j.ejcts.2010.11.082The aim of this study was to measure surrogate markers of
coagulation activation as well as of systemic inflammatory
response in patients undergoing primary elective coronary
artery bypass grafting (CABG) using either the so-called
Smart suction device or a continuous autotransfusion system
(C.A.T.S.W).
2. Patients and methods
2.1. Experimental setting
For the purpose of this study, 58 elective patients
undergoing CABGwere prospectively randomizedand assigned
to one of the following two treatment groups: group I (n = 32)
was undergoing surgery using the MECCTM System (Maquet
Cardiopulmonary AG, Hirrlingen, Germany) with the Smart
suction device (Fumedica AG, Muri, Switzerland) and group II
(n = 26) was undergoing CABG using the MECCTM System withSurgery. Published by Elsevier B.V. All rights reserved.
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Table 1. Demographics, intra and postoperative data.
Smart suction Cell saver
Demographics
Mean age (a) 65  9 62  9 0.257
EuroSCORE (add) 3.3  2.4 2.9  2.0 0.405
EuroSCORE (log) 3.2  2.5 2.5  1.5 0.202
Intraoperative data
MECC time (min) 78  33 74  21 0.621
Aortic clamp
time (min)
50  21 47  17 0.608
No of distal
anastomosis
3.53  1.02 3.42  0.76 0.795
RPBC (units) 0 0
Suction volume
(ml)
750  510 1100  540 0.012
Postoperative data
RPBC (units) 1.6  1.4 1.2  1.3 0.158
Chest tube output
(ml)
460  307 404  404 0.881
Ventilation time
(h)
18  8 18  3 0.237
In-hospital stay
(day)
7  2 7  2 0.847the C.A.T.S.W continuous autotransfusion device (Fresenius
AG, BadHomburg, Germany). Patient demographics are shown
in Table 1.
2.2. CPB and suction devices
The MECC-System used is a minimal, closed and pre-
connected extracorporeal circulation system consisting of a
hollow-fiber membrane oxygenator (Quadrox, Maquet AG,
Hirrlingen) and a centrifugal pump (RotaFlow, Maquet AG,
Hirrlingen). Arterial filter and venous bubble trap are not
used. In our setting, air was detected by an ultrasound probe,
placed on the highest level of the venous line. If air is
detected, the centrifugal pump stops immediately. Air can be
easily eliminated by opening a clamp, through the conducted
suction reservoir, which is permanent under vacuum.
The Smart suction device includes an optic fiber, which
transmits an on/off signal to a control unit, indicating
whether its end is in contact with blood. When the tip of the
suction cannula is in contact with blood, the sensor will
automatically open a clamp located in the control unit box,[()TD$FIG]Fig. 1. Set up of the MECC Smart suction system.which is assembled on the operating table. Blood will thus
immediately be aspired. When contact is lost, the clamp
closes immediately. The aspirated fluid is conducted to a
reservoir and can be returned directly into the MECCTM circuit
[9]. Fig. 1 illustrates this set-up.
The C.A.T.SW suction device is a continuous autotransfu-
sion system, which comprises a centrifugal chamber in which
the blood is collected and washed. Red blood cells are
separated from other blood components through washing
with a saline solution.
2.3. Surgery
In all patients, CABG was performed via median
sternotomy. CPB was conducted in moderate hypothermia
(34 8C). After cross-clamping the aorta, 100 ml of crystalloid
cardioplegia was injected into the aortic root [7]. In the first
group, collected suction blood was retransfused directly into
the MECCTM-System during CPB. In the second group, suction
blood was collected into the Cell Saver autotransfusion
system. After processing, red blood cells (RBCs) were
transfused to the patient in the operating theater after
weaning of CPB. Antifibrinolytic therapy was applied
according to institutional standards.
2.4. Blood sampling 1
Coagulation response was measured by the thrombin—
antithrombin complex (TAT) and D-dimer. In particular, TAT
was measured by microenzyme immunoassay (Enzygnost TAT
micro, Dade Behring Marburg GmbH, Germany), as was D-
dimer (AsserachromW D-Di).
2.5. Blood sampling 2
The inflammatory response was measured by Interleukin 6
(IL-6) and complement factor 3a (C3a). IL-6 was measured by
sandwich immunoassay using the Luminex fluorescent-bead
technology. C3a was measured by an in-house enzyme-linked
immunoassay on a Nunc MaxiSorpW plate of 96 wells. Abcam,
013-16 was used as detection antibody, gt-a-hu C3a from R&D
was used as first-capture antibody, and mouse anti-goat-IgG-
biot from Jackson Research, 205-065-108, was used as
second-capture antibody.
2.6. Time points
Blood samples were taken at three different time points,
before surgery, 2 h, and 18 h after surgery. In addition,
hematocrit was analyzed in parallel. In-hospital data were
collected, focusing on blood loss and transfusion require-
ments. We used ethylene diamine tetraacetic acid (EDTA)
plasma and D-Phenylalanyl-L-prolyl-L-arginine Chioromethyl
Ketone (C-PPACK) samples. All blood samples were centri-
fuged at latest 30 min after sampling with 3000 rpm for
30 min and pipetted into 0.5-ml tubes. Samples were stored
at 80 8C until analysis.
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Fig. 3. D-dimer serum levels over time.2.7. Statistical analysis
The statistical analysis was done using Statistical Package
for Social Sciences (SPSS) 15.0 for Windows (SPSS Inc.,
Chicago, IL, USA). Single comparisons between treatment
groups relied on the Kruskal—Wallis test; categorical data
were compared by Chi-squared tests; and repeated measures
analysis of variance (ANOVA) was used to analyze treatment




No serious adverse cardiovascular event was observed.
The number of distal anastomoses (3.5  1 for group I vs
3.4  0.8 for group II, p = 0.654) was well comparable.
Furthermore, CPB times (78  33 min vs 74  21 min,
p = 0.637) as well as aortic cross-clamp times (50  21 min
vs 47  16, p = 0.630) did not differ. Two patients had to be
excluded from the analysis due to postoperative surgical
bleeding needing revision. There were no differences with
regard to ventilation time (18  8 h vs 18  3 h, p = 0.686) as
well as in-hospital stay (7  2 days vs 7  2 days, p = 0.985).
Need for red packed blood cell substitution was during
follow-up also comparable (1.6  1.4 U vs 1.2  1.3 U,
p = 0.158). Chest tube output after 6 h (460  307 ml vs
404  404 ml, p = 0.881) and 18 h (860  441 ml vs
821  575 ml, p = 0.491) was also comparable.
3.2. Coagulation response — TAT
Serum levels of TATwere comparable between both groups
before surgery (7.05  3.66 mg l1 for group I vs
5.88  6.50 mg l1 for group II, p = 0.418). Two hours after
surgery, serum levels were significantly higher for group I
(16.12  13.51 mg l1 vs 9.83  7.81 mg l—1, p = 0.040) as
well as compared with baseline values. After 18 h, no
significant difference between both groups could be
observed (7.05  3.66 mg l—1 vs 6.29  3.41 mg l—1,
p = 0.423). Furthermore, no difference as compared with
baseline values could be observed. The ANOVAwith repeated
measures showed a significant effect for time ( p < 0.001),
but no interaction between time and study group ( p = 0.11)
was seen (Fig. 2).[()TD$FIG]
Fig. 2. TAT serum levels over time.3.3. D-dimer
Serum levels of D-dimer were comparable between both
groups before surgery (756  587 ng ml—1 for group I vs
928  1206 ng ml—1 for group II, p = 0.478). Two hours after
surgery, serum levels were significantly higher for group I
(1115  1231 ng ml—1 vs 507  604 ng ml—1, p = 0.025) as
well as compared with baseline values. After 18 h, no
significant difference between both groups could be
observed (870  442 ng ml—1 vs 721  602 ng ml—1,
p = 0.327). Furthermore, no difference as compared with
baseline values could be observed. The ANOVAwith repeated
measures showed a significant interaction between time and
treatment group ( p = 0.01) (Fig. 3).
3.4. Inflammatory response
Serum levels of IL-6 were comparable between both
groups before surgery (4  16 pg ml—1 vs 1  3 pg ml—1,
p = 0.220). Two hours after surgery, serum levels were
significantly higher for group I (186  306 pg ml—1 vs
82  71 pg ml—1, p = 0.072) as well as compared with base-
line values. After 18 h, no significant difference between
both groups could be observed (96  93 pg ml—1 vs
127  164 pg ml—1, p = 0.375). Still, a significant difference
as compared with baseline values could be observed. The
ANOVA with repeated measures showed a significant effect
for time ( p < 0.001), but no interaction between time and
study group ( p = 0.073) (Fig. 4).
Serum levels of C3a were comparable between both
groups before surgery (547  465 ng ml—1 vs
836  933 ng ml—1, p = 0.130). Two hours after surgery,
serum levels neither differed between both groups
(776  506 pg ml—1 vs 770  488 pg ml—1, p = 0.967) nor as
[()TD$FIG]
Fig. 4. IL-6 serum levels over time.
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Fig. 5. C3a serum levels over time.compared with baseline values. After 18 h, no significant
difference between both groups could be observed
(526  544 pg ml—1 vs 879  1660 pg ml—1, p = 0.262). No
significant difference as compared with baseline values could
be observed. The ANOVA with repeated measures showed no
significant effect, neither for time ( p = 0.76) nor for the
interaction between time and study group ( p = 0.383)
(Fig. 5).
4. Comment
Despite no differences in the clinical course of patients
with either Smart suction or continuous autotransfusion
system being be observed, surrogate markers of coagulation
and inflammation seem to be less pronounced in patients
where cardiotomy blood is not being directly reinfused. As
such, C.A.T.S.W should be preferred in routine CABG as long as
no extensive volume substitution is anticipated.
Drawbacks of using conventional CPB in patients under-
going CABG are well recognized. Primarily, due to volume
shifts, substantial fluid replacement may be required, and
fluid overload may affect the clinical course within the first
day after surgery [1]. This fluid overloadmay well account for
a potentially unnecessary application of red packed blood
cells. Furthermore, surrogate markers of inflammation are
upregulated, thereby enhancing the systemic inflammatory
response of the organism [2,3]. As a consequence, alter-
natives to conventional CPB were developed. A miniaturized
circuit has been implemented into clinical routine recently
with excellent results regarding clinical outcome and
simplicity of the system itself [6,7]. However, volume
replacement during CABG is needed and — as the concept
of the system is primarily a closed one — ways of sufficient
volume substitution had to be met.
Besides the routine use of an autotransfusion system,
which may — in individual situations — not be capable enough
to sufficiently preserve the fluid equilibrium, a new concept
has been introduced into clinical routine. To achieve a nearly
perfect equilibrium, the Smart system was developed [9]. By
this means, cardiotomy blood is being suctioned into a
reservoir that is directly connected to the tubing system but
separated by a manual clamp, which is being released for
fluid balancing, if needed [11]. Thereby, the concept of
volume-controlled perfusion is being realized. However, the
systemic effect may be no other than with conventional
cardiotomy suction devices, thereby leading to an increased
coagulation and inflammatory response by directly reinfusing
inflammatory mediators collected from the wound.No clinical differences between both groups were seen.
This was also not expected, as others, who have compared
autotransfusion systems and cardiotomy suction in conven-
tional CPB did also not observe significant clinical differences
regarding perioperative outcome [12,13]. Interestingly,
requirement of red packed blood cells in the operating
room (OR) in both groups was near zero, thereby substantiat-
ing the proof of principle of volume-controlled perfusion.
Furthermore, chest tube output was well comparable. It is a
fact that patients leave the OR with a stable hematocrit not
necessitating any kind of RBC transfusion. However, our
intensive care unit follows a strict regimen regarding fluid
balancing, which is not individualized according to body
surface area or weight. As such, patients with smaller body
surface area or lower weight are at risk to be in need of RBC
substitution, not due to bleeding but due to hemodilution.
Throughout this study, we have realized, fixed, and solved
this issue.
The TATas an indirect marker of thrombin generation, was
chosen as a surrogate for coagulation activation in our setting
[14]. Two hours after surgery, TATwas significantly higher in
the Smart group as compared with the C.A.T.S.W group,
thereby indicating a markedly higher coagulation activation.
Eighteen hours after surgery, serum levels returned to
baseline values in both groups. This could have been
expected as the half-value period of TAT is below this time
frame.
D-dimer was used as a surrogate marker for fibrinolysis in
this study [14]. As could be expected, according to the
changes in serum levels of TAT, D-dimer levels developed in
parallel. Therefore, a significant difference in peak values
2 h after surgery in the Smart group could be seen.
Subsequently, serum levels returned to baseline 18 h after
surgery.
As surrogate markers for the systemic inflammatory
response, we selected as surrogate for the primary
inflammatory response complement C3a as well as IL-6 as
a pro-inflammatory cytokine [1]. The second time point was
chosen as we expected the most intense increase in C3a
levels 2 h after operation [10]. C3a serum levels in patients
with a C.A.T.S.W remained constant throughout the observa-
tion, whereas C3a serum levels in patients with the Smart
system showed a marked increase 2 h after surgery. However,
due to a broad standard deviation at baseline, these values
did not reach statistical significance.
IL-6 serum levels increased 2 h after surgery reaching
borderline significance and then decreased again indicating a
higher level of inflammation in patients with the Smart
system than in patients in whom a C.A.T.S.W has been used.
Overall, regarding surrogate markers of coagulation as well
as inflammation, differences between both groups are
measurable; however, serum levels return to baseline
quickly. Furthermore, there was no clinical impact related
our findings. As such, the manifest means of immediate
volume substitution may be of higher value than a non-
manifest but measurable difference in serum surrogate
markers.
Clinics and surrogate markers of inflammation do not
always accord. As such, it remains speculative if a switch to
an autologous transfusion device may, in fact, affect
outcome. To prove this hypothesis, a substantially larger
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this study — there are no differences in outcome regarding
clinical end points. Whether this change of strategy might
influence more subtle parameters such as cognitive brain
function, which is directly influenced by inflammation,
remains the subject of further investigations [15].
Summarizing, despite no differences in the clinical course
of patients with either Smart suction or C.A.T.S.W being be
observed, surrogate markers of coagulation and inflamma-
tion seem to be less pronounced in patients where
cardiotomy blood is not being directly reinfused. As such,
C.A.T.S.W should be preferred in routine CABG as long as no
extensive volume substitution is anticipated.
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